← Research ProtocolsNAD+
STUDIED EXPOSURE MAP / 2019
NAD+
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
HUMAN / IV PILOTFRONTIERS IN AGING NEUROSCIENCESTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
750 mg total
IV over 6 hours
3 µmol/min
infusion rate reported by paper
Context: The paper reports both the total amount and molar infusion rate. This is a pharmacokinetic/metabolomic pilot, not proof of a clinical benefit.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / FRONTIERS IN AGING NEUROSCIENCE
A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
2019
01 / DESIGNHuman metabolic pilot study
02 / POPULATION / MODELHuman participants receiving a controlled IV infusion
03 / ROUTEIntravenous infusion
04 / TIMEFRAME6-hour infusion with 8-hour sampling
05 / PRIMARY QUESTIONPlasma and urinary NAD+ metabolome
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
Cellular redox and energy-metabolism research
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.